MYND Life Sciences Inc. (MYND.CN)
CAD 0.07
(-30.0%)
CAD 0.07
(-30.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.82 Million CAD | 39.23% |
| 2022 | -2.97 Million CAD | 28.58% |
| 2021 | -4.31 Million CAD | 0.0% |
| 2020 | - CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -220.58 Thousand CAD | 33.92% |
| 2024 Q1 | -333.78 Thousand CAD | 13.9% |
| 2024 Q3 | -341.69 Thousand CAD | -54.91% |
| 2023 Q4 | -391 Thousand CAD | -24.71% |
| 2023 Q2 | -428.97 Thousand CAD | 32.36% |
| 2023 Q1 | -634.25 Thousand CAD | -4.54% |
| 2023 FY | - CAD | 39.7% |
| 2023 Q3 | -313.53 Thousand CAD | 26.91% |
| 2022 Q3 | -671.12 Thousand CAD | 4.43% |
| 2022 Q2 | -702.22 Thousand CAD | 38.0% |
| 2022 Q1 | -1.13 Million CAD | 28.08% |
| 2022 FY | - CAD | 28.58% |
| 2022 Q4 | -606.72 Thousand CAD | 9.6% |
| 2021 Q3 | -817.44 Thousand CAD | -10.17% |
| 2021 FY | - CAD | 0.0% |
| 2021 Q2 | -741.97 Thousand CAD | 36.38% |
| 2021 Q4 | -1.57 Million CAD | -92.66% |
| 2021 Q1 | -1.16 Million CAD | 0.0% |
| 2020 FY | - CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -4.98 Million CAD | 63.36% |
| Asep Medical Holdings Inc | -8.13 Million CAD | 77.566% |
| BetterLife Pharma Inc. | -3.19 Million CAD | 42.81% |
| BioVaxys Technology Corp. | -7.68 Million CAD | 76.257% |
| ChitogenX Inc. | -2.69 Million CAD | 32.25% |
| Rapid Dose Therapeutics Corp. | -3.02 Million CAD | 39.658% |
| Defence Therapeutics Inc. | -12.67 Million CAD | 85.601% |
| Entheon Biomedical Corp. | 13.99 Thousand CAD | 13143.636% |
| Gemina Laboratories Ltd. | -5.17 Million CAD | 64.736% |
| Glow Lifetech Corp. | -1.26 Million CAD | -44.508% |
| Lexston Life Sciences Corp. | -648.32 Thousand CAD | -181.525% |
| Pharmala Biotech Holdings Inc. | -710.18 Thousand CAD | -157.003% |
| Doseology Sciences Inc. | -319.47 Thousand CAD | -471.306% |
| Nova Mentis Life Science Corp. | -1.2 Million CAD | -51.809% |
| PharmaTher Holdings Ltd. | -3.04 Million CAD | 40.027% |
| PreveCeutical Medical Inc. | -955.08 Thousand CAD | -91.102% |
| Telescope Innovations Corp. | -5.49 Million CAD | 66.757% |